RWD129 A Comparison of ICU Admission Rate and Related Cost Among Patients Taking Nirmatrelvir and Ritonavir Combination Versus Molnupiravir for Treatment of Mild to Moderate COVID-19 in the US
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2354
https://www.valueinhealthjournal.com/article/S1098-3015(22)04559-4/fulltext
Title :
RWD129 A Comparison of ICU Admission Rate and Related Cost Among Patients Taking Nirmatrelvir and Ritonavir Combination Versus Molnupiravir for Treatment of Mild to Moderate COVID-19 in the US
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04559-4&doi=10.1016/j.jval.2022.09.2354
First page :
Section Title :
Open access? :
No
Section Order :
11917